Skip to search formSkip to main contentSkip to account menu

Lafora bodies

An intraneuronal inclusion body composed of acid mucopolysaccharides. [HPO:sdoelken]
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Lafora disease (LD) is a fatal childhood epilepsy and a non-classical glycogen storage disorder with no effective therapy or cure… 
2018
2018
Lafora disease (LD) is a fatal form of progressive myoclonus epilepsy characterized by the accumulation of insoluble poorly… 
Highly Cited
2014
Highly Cited
2014
Glycogen is a branched polymer of glucose and the carbohydrate energy store for animal cells. In the brain, it is essentially… 
Highly Cited
2012
Highly Cited
2012
Lafora disease (LD), a fatal neurodegenerative disorder characterized by the presence of intracellular inclusions called Lafora… 
Highly Cited
2007
Highly Cited
2007
Protein Tyrosine Phosphatases (PTPases) are a large family of catalyst that play critical roles in regulating reversible… 
Highly Cited
2005
Highly Cited
2005
Progressive Myoclonus Epilepsy (PME) of the Lafora type is an autosomal recessive disease, which presents in teenage years with… 
Highly Cited
2005
Highly Cited
2005
Lafora progressive myoclonus epilepsy, caused by defective laforin or malin, insidiously present in normal teenagers with… 
Highly Cited
2004
Highly Cited
2004
Lafora disease (LD) is a fatal and the most common form of adolescent-onset progressive epilepsy. Fulminant endoplasmic reticulum… 
Highly Cited
1968
Highly Cited
1968
THE LAFORA body form of myoclonus epilepsy is a genetically-determined (recessive) disease. It usually begins clinically in the…